StockpollyBeta
Get App
Popularity #330
RXRX · NASDAQ · Biotechnology

Recursion Pharmaceuticals (RXRX)

Builds investigational medicines through automated biology, AI chemistry, and partner programs.

$4.02
After hours−0.03 (−0.75%)
At close$4.05(+2.02%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue10111314265151953668
Cost of revenue11101191213222030271211
Gross profit−112514−8−7−1−249−6−4
9910099106112175184175148117122131
Research & development706968747598130129121838890
293031323877554742343542
General & administrative293031323877554742343542
Other expenses00000000−15000
Operating income−100−99−96−101−98−184−191−176−172−108−129−135
724235−11410064
Interest income554345656665
Interest expense000011101000
Other non-operating income−7−2−4−3−3−511−5−100−7−4
Income before tax−93−97−92−98−96−179−203−172−162−108−122−131
Income tax expense0−4−1−1000000−50
Net income from continuing operations−93−93−91−98−96−179−202−172−162−108−118−131
Other adjustments000000000000
Net income−93−93−91−98−96−179−202−172−162−108−118−131
EPS, basic−$0.43−$0.40−$0.39−$0.40−$0.34−$0.53−$0.50−$0.41−$0.36−$0.21−$0.22−$0.25
EPS, diluted−$0.43−$0.40−$0.39−$0.40−$0.34−$0.53−$0.50−$0.41−$0.36−$0.21−$0.22−$0.25
Weighted average shares, basic214233236242283336403417447527529532
Weighted average shares, diluted214233236242283336403417447527529532
EBITDA−85−89−85−89−88−165−183−148−141−89−102−113
Depreciation & amortization8879713192421192018
EBIT−93−97−92−98−95−178−202−171−162−108−122−131